It seems to have been clearly established that amounts received for the sterilisation of assets, apart from instances where they have been rendered temporarily inoperative, are receipts of capital. Many such receipts would today constitute chargeable gains: see ¶514-600.

Need help? Get subscribed!

To subscribe to this content, simply call 0800 231 5199

We can create a package that’s catered to your individual needs.

Or book a demo to see this product in action.